Back to results
US 12,011,450 B2Granted
Polyethylene glycol-conjugated glucocorticoid prodrugs and compositions and methods thereof
AssigneeBoard of Regents of the University of Nebraska
InventorsDong Wang, Fang Yuan, Zhenshan Jia, Xiaobei Wang
Life of this patent
Estimating the term…
Abstract
Polyethylene glycol (PEG)-conjugated glucocorticoid prodrugs, methods of preparation, and use for the treatment of diseases and disorders are disclosed. In particular, PEG-conjugated dexamethasone compounds and methods of using them for treating inflammatory and autoimmune diseases, including but not limited to lupus, are disclosed.
Claims20
A method of preparing a glucocorticoid prodrug compound of formula (XII):
- or a pharmaceutically acceptable salt thereof;
- wherein:
- n is an integer selected from 10 to 300;
- m is 1, 2, 3, or 4;
- w is 1 or 2;
- GC is a moiety of a glucocorticoid drug molecule;
- A is absent or C1-C6 alkylene;
- B is absent, NH, or C(O);
- D is absent, NH, O, or C(O);
- E is a linker selected from:
- where i and j are independently 0 or an integer selected from 1 to 5;
- G is NH;
- P is absent or C(O);
- Q is absent or C1-C6 alkylene;
- T is absent or C(O);
- X is absent, O, or NH;
- Y is absent, C(O), or C1-C6 alkylene;
- Z is absent, NR4, O, C1-C6 alkylene, or a linker comprising a branched structure capable of connecting to one or more glucocorticoid drug molecular moieties, said linker optionally comprising one or more heteroatoms independently selected from O, S, and N;
- and
- R1 is H, C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C6-C10 aryl, 5-10 membered heteroaryl, or 5-10 membered heterocyclyl, each group except H optionally substituted;
- R4 at each occurrence is independently H or C1-C4 alkyl;
- wherein when any of A, B, D, E, G, P, Q, T, X, Y, and Z groups is absent, its two available adjacent groups are single-bonded to each other directly,
- the method comprising steps of:
- (a1) coupling a linker compound comprising a moiety of structure E with a glucocorticoid hydrazone derivative of formula (A) or (B) to form an intermediate;
- and
- (b1) coupling the intermediate with a polyethylene glycol derivative selected from PEG-OH, PEG-NH2, PEG-CO2H, and PEG-CO2R10 to form a precursor compound to the compound of structure (XII) comprising one or more OH-protecting groups;
- or
- alternatively, (a2) coupling a linker compound comprising a moiety of structure E with a polyethylene glycol derivative selected from PEG-OH, PEG-NH2, PEG-CO2H, and PEG-CO2R10 to form an intermediate;
- and
- (b2) coupling the intermediate with a glucocorticoid hydrazone derivative of formula (A) or (B) to form a precursor compound to the compound of structure (XII) comprising one or more OH-protecting groups;
- and
- (c) removing the OH-protecting groups from the precursor compound to obtain the compound of structure (XII),
- wherein R10 is C1-C4 alkyl.
30 more elements
Dependencies are inferred from the claim text.